top of page

One test,

hundreds possibilities,

one answer.

Germ-specific diagnosis is hard

but necessary

Inappropriate treatment does not prevent hospitalization (40%, of >65 with pneumonia end up hospitalized), and antibiotic misuse leads to antimicrobial resistance

Deck series A v13WEBSITE copia_edited.jpg

02

Doctors can diagnose pneumonia, but cannot easily identify the underlying microorganism

03

By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral

04

Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)

01

Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide

05

Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050

Our Team

Jordan Parker

Position / Role

Max Johnson

Position / Role

Drew Carlyle

Position / Role

Morgan James

Position / Role

Any sample works

Compatible with respiratory swab, blood, urine, saliva, stool…

On site

Can sit on a desk, no lab required

Fast

Result in <10

minutes

Fast

Cost per bug $2

Quantitative

Customizable panel of 50+ viruses, bacteria, and fungi in 1 test

ed384bae-c74d-469b-af38-ba9644203bde.JPG
3b910169-1b89-4454-afee-cafd56d6400b.JPG

One test to rule them all

About

We are developing a quantitative analysis capable of detecting all microrganisms in both clinical and non-clinical samples, using a fast and cheap technology which can be deployed at the point of care.

Fig_v20_raster_LQ_3.png

How it works

Fig_v20_raster_LQ_2.png

Meet the Founders

Giulio Deangeli 

MD, PhDc, MBiotech, MMedSci, BEng

Forbes 30 under 30, North America

Final year PhD candidate in AI, Cambridge

5 degrees in parallel, summa cum laude

Harvard HIP Scholarship, ranked in top 5%

World Vice-Champion Neuroscience, IBB

2 books, papers in Science, Cell, Brain

Cristiano Peron

MD, PhD

PhD in translational medicine, Oxford

Clinical Fellow Oxford University Hospital

Fellow, Robert Langer’s family office

Medical Doctor, summa cum laude

Armenise-Harvard Fellowship, Harvard

Papers in Cell and other journals

Fidi.jpg

Fidelius von Rehlingen-Prinz

MD, PhD, MBAc

Advisory board, Kaliber Labs Inc., San Francisco

Medical advisor, Longevital, Munich

CFO, Sustain Surgical Inc., New York

PhD in receptor-specific therapies, Nuremberg

Medical Doctor, summa cum laude

Papers in leading clinical journals

How it works

Competitor approaches

table.png

Device intrinsic value < $8,000, consumables

< $20-30 /test

Germ-specific diagnosis is hard

but necessary

Inappropriate treatment does not prevent hospitalization (40%, of >65 with pneumonia end up hospitalized), and antibiotic misuse leads to antimicrobial resistance

Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050

Deck series A v13WEBSITE copia_edited_edited.jpg

05

04

Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)

03

By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral

Doctors can diagnose 

pneumonia, but cannot

easily identify the underlying

microorganism

02

01

Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide

01

Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide

02

Doctors can diagnose 

pneumonia, but cannot

easily identify the underlying

microorganism

03

By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral

04

Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)

01

Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide

05

Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050

Any sample works

Compatible with respiratory swab, blood, urine, saliva, stool…

Point of care

Can sit on a desk, no lab required

Fast

Result in 10-15 minutes

Cheap

Device intrinsic value

< $10,000, consumables

< $50 /test

Quantitative

Customizable panel of 50+ viruses, bacteria, and fungi in 1 test

Point of care

Can sit on a desk, no lab required

Fast

Result in 10-15 minutes

Cheap

Device intrinsic value

< $10,000, consumables

< $50 /test

Quantitative

Customizable panel of 50+ viruses, bacteria, and fungi in 1 test

One test to rule them all

Competitor approaches

Fig_v20_raster_LQ_1.png

Giulio Deangeli 

2024 - Final year PhD candidate, University of Cambridge

2021 - «100 number ones» by Forbes

2020 - 5 university courses in parallel, 30/30 GPA

2018 - Harvard HIP Scholarship, ranked in top 5%

2016 - Amgen Scholarship, Cambridge, ranked #1

2013 - World Vice-Champion Neuroscience, IBB

Author of 2 books; papers in Science, Cell and Brain

MD, PhDc, MBiotech, MMedSci, BEng

Cristiano Peron

2023 - PhD, University of Oxford

2023 - Clinical Fellow Oxford University Hospital

2021 - Old Silver VC Fellow, Boston

2019 - Medical Doctor, summa cum laude

2018 - Armenise-Harvard Fellowship, Harvard University

2017 - IEF Fellowship, Columbia university

Author of papers in Cell and other peer reviewed journals

MD, PhD

Meet the Founders

Meet the Founders

bottom of page